Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04903028 · ClinicalTrials.gov registry record · NA
RTMS Targets Neural Circuits for Smoking Cessation
A NA study of Tobacco Use and Cigarette Smoking, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT04903028: Recruiting NA study of Tobacco Use and Cigarette Smoking, sponsored by Medical University of South Carolina.
NCT04903028 is a NA study of Tobacco Use and Cigarette Smoking that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 64 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04903028, a NA study of Tobacco Use and Cigarette Smoking, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, investigators will use brain MRI to guide TMS therapy for smoking cessation.
Primary Outcome
Measured by self-report of smoking abstinence in the past 4 weeks and confirmed using urine cotinine measurement.
Conditions Studied
Interventions
- DEVICE Sham rTMS
- DEVICE Active rTMS 10 Hz DLPFC
Study Locations (2)
South Carolina
- Medical University of South Carolina - Charleston
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-05-15 |
| Est. Completion | 2027-04-04 |
| Phase | NA |
What NCT04903028 shows while recruiting
NCT04903028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Sham rTMS is the first listed.
NCT04903028 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT04903028 about?
NCT04903028 is a clinical study titled "RTMS Targets Neural Circuits for Smoking Cessation". Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, in...
What is the current status of trial NCT04903028?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2021-05-15. Estimated completion is 2027-04-04.
What conditions does trial NCT04903028 study?
This clinical trial studies the following conditions: Tobacco Use, Cigarette Smoking.
What interventions are being tested in trial NCT04903028?
The interventions under investigation include: Sham rTMS (DEVICE), Active rTMS 10 Hz DLPFC (DEVICE).
Who is sponsoring clinical trial NCT04903028?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04903028 being conducted?
This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04903028's enrollment target sits among peer trials
64 47th of 76 higher than 29 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI